David Shaw’s Zimmer Biomet ZBH Stock Holding History

David Shaw’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Buy	+22,400	New	+$1.96M	﹤0.01%	3237
2026 Q1	–	Sell	-25,100	Closed	-$2.26M	–	5140
2025 Q4	$2.26M	Buy	+25,100	New	+$2.38M	﹤0.01%	2956
2022 Q4	–	Sell	-25,000	Closed	-$2.61M	–	5170
2022 Q3	$2.61M	Hold	25,000	–	–	﹤0.01%	2752
2022 Q2	$2.63M	Hold	25,000	–	–	﹤0.01%	2825
2022 Q1	$3.2M	Sell	25,000 -750	-3%	-$90.4K	﹤0.01%	2816
2021 Q4	$3.18M	Buy	+25,750	New	+$3.37M	﹤0.01%	2896
2019 Q2	–	Sell	-13,905	Closed	-$1.72M	–	3916
2019 Q1	$1.72M	Buy	+13,905	New	+$1.58M	﹤0.01%	2264
2017 Q2	–	Sell	-10,300	Closed	-$1.22M	–	3570
2017 Q1	$1.22M	Buy	+10,300	New	+$1.17M	﹤0.01%	2174
2014 Q4	–	Sell	-10,300	Closed	-$1.01M	–	4294
2014 Q3	$1.01M	Sell	10,300 -6,901	-40%	-$679K	﹤0.01%	2807
2014 Q2	$1.73M	Buy	+17,201	New	+$1.68M	﹤0.01%	2424
2014 Q1	–	Sell	-70,761	Closed	-$6.4M	–	4679
2013 Q4	$6.4M	Sell	70,761 -40,582	-36%	-$3.51M	0.01%	1476
2013 Q3	$8.88M	Hold	111,343	–	–	0.01%	1109
2013 Q2	$8.1M	Buy	+111,343	New	+$8.33M	0.02%	1009

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

David Shaw's ZBH Position: Q2 2026 in Review

David Shaw increased its Zimmer Biomet (ZBH) stake by 164% in Q2 2026, buying an estimated $1.31M and bringing the position to 24,120 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3171.

David Shaw first reported a position in ZBH in Q2 2013 and has held it in 51 quarters since. The position peaked at $156M in Q4 2015. 904 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

David Shaw held 24,120 shares of Zimmer Biomet worth $2.08M as of Q2 2026.
David Shaw bought 14,974 Zimmer Biomet shares in Q2 2026, an estimated $1.31M.
Zimmer Biomet made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3171 holding.
David Shaw first reported a position in Zimmer Biomet in Q2 2013 and has held it in 51 quarters since.
David Shaw's Zimmer Biomet position peaked at $156M in Q4 2015.
904 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.